BioLargo (OTC:BLGO) Stock, Quote.Headers.trade-ideas

BIOLARGO, INC.

BioLargo Inc invents, develops, and commercializes platform technologies to solve challenging environmental problems like PFAS contamination, water, and wastewater treatment, industrial odor, and VOC control, air quality control, and infection control. The company has five segments: ONM Environmental; Clyra Medical; BLEST; BioLargo Canada and BioLargo corporate. ONM Environmental which sells odor and volatile organic control products and services, located in Westminster, California derives the maximum revenue.

News

Penny Stocks

Commodities

Global

Markets

Tech

Trading Ideas

AZURF

BLGO

BURCF

MEDAD

Nuveen Arizona Dividend Advantage Municipal Funds 3

REVVF

RTNTF

SYHBF

TCEFF

VOYRD

AI Data Centers, EVs to Lead New Surge in Energy Demand

Screenshot 2024-05-22 at 5.58.01 PM

Emerging Markets

Movers & Shakers

Interview

6 Years Of Revenue Growth For Leading Clean Tech Company Now Combating Dangerous PFAS Chemicals

New Regulations May Be Coming To Combat Dangerous “Forever Chemicals” – This Cleantech Innovator Is Ready

General

Dennis Calvert, President &amp; CEO of BioLargo Inc. (OTCQB: BLGO) was recently a guest on Benzinga’s All-Access.

New Regulations May Be Coming To Combat Dangerous &#34;Forever Chemicals&#34; – This Cleantech Innovator Is Ready

BioLargo Inc

Catalyst Watch:  Fed rates meeting, Nvidia CEO speaks at GTC 2024, Reddit IPO

BioLargo reports Q4 results

BioLargo GAAP EPS of $0.00, revenue of $4.76M

The latest announcement is out from BioLargo Inc (BLGO). BioLargo, Inc. is set to engage investors with a webcast presentation on May 14, 2024, sha...

BioLargo Inc Hosts Investor Webcast Presentation in May

The latest announcement is out from BioLargo (BLGO). BioLargo, Inc. is gearing up for its annual stockholder meeting, scheduled for June 13, 2024, ...

BioLargo's Annual Meeting Scheduled for June 2024

BioLargo unit secures contract to provide air quality services

BioLargo, Inc. 2024 Q1 - Results - Earnings Call Presentation

BioLargo reports Q2 results

BioLargo, Inc. (BLGO) Q2 2024 Earnings Call Transcript

The latest update is out from BioLargo (BLGO). BioLargo, Inc. showcased its latest slides during a webcast investor conference, emphasizing that th...

BioLargo Presents Corporate Update in Investor Webcast

ALAB

ALTR

ANTX

ASTA

AVGO

AXNX

BYND

CHWY

CMTL

CSPI

CTRN

DWAC

FATH

FIVE

LULU

NVDA

PGTI

QDEL

RDDT

SAIC

SHEL

SMCI

SNPS

SPWR

SSRM

STER

STNE

Press Releases

BioLargo Engineering Secures Multi-Year Air Force Base Air Compliance Project

BioLargo Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion

BioLargo Subsidiary Clyra Medical Selects Keystone Industries to Support Manufacturing of its Medical Products

BioLargo Engineering Increases Ongoing Revenue with Another Air Force Contract

Earnings

BioLargo Achieves Record Quarterly Revenue of $5 Million for Second Quarter of 2024

BioLargo Earnings Results Webcast and Conference Call on Wednesday, August 14, 2024 - 1:30 PM Pacific Time

Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY

Clyra Medical Technologies, a Subsidiary of BioLargo, Appoints Dr. Steven J. Kavros as Chief Medical Officer

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

BioLargo

BioLargo (BLGO) Forecast

BioLargo (OTC:BLGO) Stock, Quote.Headers.trade-ideas